tiprankstipranks
Syneos Health (NASDAQ:SYNH) Dips after Updating Outlook
Market News

Syneos Health (NASDAQ:SYNH) Dips after Updating Outlook

Shares of biopharmaceutical contract research services provider Syneos Health (NASDAQ:SYNH) are trending lower today after the company’s outlook failed to buoy investor sentiment. SYNH now sees its Clinical Solutions book-to-bill ratio over the trailing 12 months ended September 30 hovering between 1.05x and 1.15x (excluding reimbursable expenses).

Syneos is presenting at the 2022 Baird Global Healthcare Conference today.

Is Syneos Health a Buy Right Now?

Barclays analyst Luke Sergott has reiterated a Buy rating on SYNH alongside a price target of $70. The Street though is cautiously optimistic about the stock with a Moderate Buy consensus rating.

The average analyst price target of $78 indicates a 40.04% potential upside in SYNH. That’s after a 19.2% slump in the stock price over the past month.

Read full Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles